Celator Pharmaceuticals, Inc. Issued U.S. Patent Related to CombiPlex(R) Technology Platform

Published: Dec 16, 2010

PRINCETON, N.J.--(BUSINESS WIRE)--Celator Pharmaceuticals today announced the United States Patent and Trademark Office issued U.S Patent No. 7,850,990. This patent adds to the intellectual property surrounding Celator’s innovative technology platforms and products.

Back to news